Haemorrhagic transformation of an ischaemic infarct
Haemorrhagic transformation is a complication of cerebral ischaemic infarction and can significantly worsen prognosis.
It should be noted that the term haemorrhagic transformation is a little variably used and collectively refers to two different processes, which have different incidence, appearance and prognostic implications. These are:
- petechial haemorrhage
- intracerebral haematoma
As such when using the term one should try and be explicit as to which of these one is referring to.
ECASS II classification
A commonly used classification system was developed for the European Cooperative Acute Stroke Study (ECASS II), which divides haemorrhagic transformation into 4 subtypes 9:
- haemorrhagic infarction type 1 (HI1)
- petechial haemorrhages at the infarct margins
- haemorrhagic infarction type 2 (HI2)
- petechial haemorrhages throughout the infarct
- no mass-effect attributable to the haemorrhages
- parenchymal hematoma type 1 (PH1)
- ≤30% of the infarcted area
- minor mass-effect attributable to the haematoma
- parenchymal hematoma type 2 (PH2)
- >30% of infarct zone
- substantial mass-effect attributable to the haematoma
The patient group affected is a subset of those affected by cerebral infarction, and thus is dominated by the elderly with multiple cardiovascular risk factors.
The rates of haemorrhagic transformation of ischaemic strokes have been variably reported, but generally over half of all cerebral infarcts at some stage develop some haemorrhagic component, although the majority (89%) are petechial haemorrhages, and a minority (11%) haematomas 5-6. Importantly cardioembolic strokes, especially large ones, are more likely to undergo haemorrhagic transformation than atherothrombotic strokes 1.
Although haemorrhagic transformation can occur spontaneously, it is more frequently encountered in patients who receive anticoagulant therapy and even more frequent in those undergoing thrombolytic therapy 1-2,4. The overall rate of spontaneous haemorrhagic transformation (with haematoma) has been reported to be as high as ~5% 5.
The incidence of symptomatic haemorrhagic transformation is, however, much lower, between 0.6 and 3% in untreated patients and up to 6% of patients treated with IV tP 2,4,6.
Predictors of haemorrhagic transformation when thrombolysis is used include 6:
- severe strokes (NIHSS >14)
- proximal middle cerebral artery occlusion
- hypodensity (CT) affecting >1/3 of the middle cerebral artery territory
- delayed recanalisation (>6 hours after stroke onset)
- absence of collateral flow
Significant haemorrhagic transformation of a cerebral infarct usually manifests in a rapid and often profound deterioration in clinical state.
In untreated patients, haemorrhagic transformation rarely occurs in the first 6 hours. It is usually seen in the first few days, the majority within 4 days of infarction. In patients who have been treated acutely with thrombolysis or thrombectomy, haemorrhage occurs in the vast majority within 24 hours of the start of treatment 3.
Petechial haemorrhagic transformation has traditionally been referred to by pathologists as "red softening" in contrast to the more common bland or anaemic infarct.
It is believed that haemorrhagic transformation occurs as a result of preserved collateral perfusion (from adjacent vessels/territories) or from reperfusion of infarcted tissues which have weakened vessels (i.e. from extravasation or diapedesis) 1. The former explains why haemorrhagic transformation is seen in patients with permanently occluded vessels. The latter accounts for the increased incidence in patients receiving therapies designed to increase reperfusion rates.
The radiographic features differ for petechial haemorrhage and secondary haematoma.
Petechial haemorrhages, as the name suggests, usually appear as tiny punctate regions of haemorrhage, often not able to be individually resolved, but rather resulting in increased attenuation of the region on CT of signal loss on MRI. Although this petechial change can result in cortex appearing near-normal it should not be confused with the phenomenon of fogging seen on CT which occurs 2 to 3 weeks after infarction.
In the case of secondary haematomas, the radiographic features on both CT and MRI are merely a summation of the features of an ischaemic infarct, with superimposed cerebral haemorrhage. The amount of haemorrhage relative the size of the infarct can vary widely, but usually, it is possible to identify significant areas of the brain which are infarcted but not haemorrhagic. This may not be the case if the haemorrhage is large and the underlying infarct small.
Petechial haemorrhage typically is more pronounced in grey matter and results in increased attenuation. This sometimes mimics normal grey matter density and contributes to the phenomenon of fogging.
By the time secondary haematomas form, the underlying infarct should be easily seen and will appear as a region of low attenuation, involving both the white matter and the overlying cortex. Haemorrhage is often patchy, scattered throughout the infarcted tissue, and usually represents only a small component of the abnormal tissue 1.
Appearances of MRI are as expected for an ischaemic stroke, demonstrating restricted diffusion on DWI/ADC sequences. Sequences susceptible to signal drop out due to blood products (especially SWI) are useful as they are more sensitive than CT to early haemorrhage and may help direct therapy (e.g. withhold thrombolytic therapy) although they are difficult to obtain in the hyperacute setting.
Treatment and prognosis
In the case of petechial haemorrhage, neither prognosis or treatment are usually affected. The same cannot be said for secondary haematomas, which when large can have a dramatic negative impact on survival and morbidity. In fact, in many thrombolysis trials, it is these secondary haematomas which almost offset the gains made by successful reperfusion.
- contrast staining post contrast administration (e.g. for endovascular stroke treatment) 7,8
- follow-up CT performed 19-24 hours following intervention is the most specific way to differentiate, with persistent hyperdensity consistent with haemorrhage as contrast staining will reduce in density over time 7
Stroke and intracranial haemorrhage
stroke and intracranial haemorrhage
- general discussions
- scoring and classification systems
- by region
- hemispheric infarcts
- frontal lobe infarct
- parietal lobe infarct
- temporal lobe infarct
- occipital lobe infarct
- internal capsule infarct
- ataxic hemiparesis syndrome: MCA perforators or basilar artery perforators
- lacunar infarct
- thalamic infarct
- cerebellar infarct
- midbrain infarct
- pontine infarct
- medullary infarct
- acute spinal cord ischaemia syndrome
- hemispheric infarcts
- by vascular territory
- anterior cerebral artery infarct
- anterior choroidal artery infarct
- anterior inferior cerebellar artery infarct
- basilar artery infarct
- middle cerebral artery infarct
- posterior cerebral artery infarct
- posterior inferior cerebellar artery infarct
- superior cerebellar artery infarct
- basal ganglia haemorrhage
- cerebellar haemorrhage
- cerebral contusions
- CTA spot sign
- haemorrhagic venous infarct
- haemorrhagic transformation of an ischaemic infarct
- hypertensive intracranial haemorrhage
- intraventricular haemorrhage (IVH)
- lobar haemorrhage
- pontine haemorrhage
- remote cerebellar haemorrhage
- extra-axial haemorrhage
- extradural haemorrhage (EDH)
- intralaminar dural haemorrhage
- subdural haemorrhage (SDH)
- subarachnoid haemorrhage (SAH)
- intra-axial haemorrhage
- ischaemic stroke
- 1. Atlas SW. Magnetic Resonance Imaging Of The Brain And Spine. Lippincott Williams & Wilkins. (2009) ISBN:078176985X. Read it at Google Books - Find it at Amazon
- 2. Hacke W, Kaste M, Bluhmki E et-al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N. Engl. J. Med. 2008;359 (13): 1317-29. doi:10.1056/NEJMoa0804656 - Pubmed citation
- 3. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group. Stroke. 1997;28 (11): 2109-18. Stroke (full text) - doi:10.1161/01.STR.28.11.2109 - Pubmed citation
- 4. . Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N. Engl. J. Med. 1995;333 (24): 1581-7. doi:10.1056/NEJM199512143332401 - Pubmed citation
- 5. Toni D, Fiorelli M, Bastianello S et-al. Hemorrhagic transformation of brain infarct: predictability in the first 5 hours from stroke onset and influence on clinical outcome. Neurology. 1996;46 (2): 341-5. Neurology (full text) - doi:10.1212/WNL.46.2.341 - Pubmed citation
- 6. Arboix A, Alió J. Cardioembolic stroke: clinical features, specific cardiac disorders and prognosis. Curr Cardiol Rev. 2010;6 (3): 150-61. doi:10.2174/157340310791658730 - Free text at pubmed - Pubmed citation
- 7. Dekeyzer S, Nikoubashman O, Lutin B et-al. Distinction between contrast staining and hemorrhage after endovascular stroke treatment: one CT is not enough. J Neurointerv Surg. doi:10.1136/neurintsurg-2016-012290 - Pubmed citation
- 8. Ho SK, Lee JK, Lai YJ et-al. Differentiating contrast staining after acute ischemic stroke from hemorrhagic transformation during emergency evaluation. Am J Emerg Med. 2016; . doi:10.1016/j.ajem.2016.05.035 - Pubmed citation
- 9. Vincent Larrue, Rüdiger von Kummer, Achim Müller, Erich Bluhmki. Risk Factors for Severe Hemorrhagic Transformation in Ischemic Stroke Patients Treated With Recombinant Tissue Plasminogen Activator. Stroke. 32 (2): 438. doi:10.1161/01.STR.32.2.438 - Pubmed